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Abstract
How epigenetic information is propagated during somatic cell divisions is still unclear but is absolutely critical for preserving
gene expression patterns and cellular identity. Here we show an unanticipated mechanism for inheritance of DNA
methylation patterns where the epigenetic mark not only recruits the catalyzing enzyme but also regulates the protein
level, i.e. the enzymatic product (5-methylcytosine) determines the level of the methylase, thus forming a novel homeostatic
inheritance system. Nucleosomes containing methylated DNA stabilize de novo DNA methyltransferases, DNMT3A/3B,
allowing little free DNMT3A/3B enzymes to exist in the nucleus. Stabilization of DNMT3A/3B on nucleosomes in methylated
regions further promotes propagation of DNA methylation. However, reduction of cellular DNA methylation levels creating
more potential CpG substrates counter-intuitively results in a dramatic decrease of DNMT3A/3B proteins due to diminished
nucleosome binding and subsequent degradation of the unstable free proteins. These data show an unexpected self-
regulatory inheritance mechanism that not only ensures somatic propagation of methylated states by DNMT1 and
DNMT3A/3B enzymes but also prevents aberrant de novo methylation by causing degradation of free DNMT3A/3B enzymes.
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Introduction
DNA methylation is a stable gene silencing mechanism required
for key biological processes including embryogenesis, genomic
imprinting, X-chromosome inactivation, repression of transposons
and maintenance of tissue specific gene expression patterns [1,2].
Aberrant methylation contributes to tumorigenesis and other
diseases [3,4]. Thus, proper maintenance of DNA methylation
patterns is essential for preserving cellular identity and preventing
malignant cellular transformation.
In mammals, DNA methylation patterns are generally thought
to be established during embryonic development by de novo DNA
methyltransferases 3A and 3B [5] and then stably maintained
through multiple somatic divisions by the ‘maintenance activity’ of
DNMT1 both during and after replication [6]. However, recent
studies suggest that DNMT1 alone cannot ensure proper
maintenance of methylation patterns [7] and requires co-operative
activity of the de novo DNMT3A/3B enzymes [8,9,10], which are
ubiquitously expressed in somatic cells. A revised model of
inheritance was recently proposed assigning DNMT3A/3B to a
maintenance role in somatic cells [11]; however, questions still
remain regarding the molecular mechanisms guiding the mainte-
nance activity of these de novo enzymes.
In embryonic stem (ES) cells, DNMT3A/3B establish methyl-
ation patterns in association with DNMT3L, a regulatory factor
which stimulates DNMT3A/3B de novo activity [12] and targets
them to nucleosomes containing unmethylated H3K4 residues
[13]. Methylated H3K4 containing chromatin regions remain
refractory to such DNA methylation [14,15]. Further, heterochro-
matin protein 1 (HP1) recruits DNMT3A/3B to H3K9me3
residues, established by histone methyltransferase (HMTase)
Suv39h1/2, enabling de novo DNA methylation in pericentric
heterochromatin [16]. In euchromatic regions, G9a, another
H3K9 HMTase, recruits DNMT3A/3B for de novo methylation of
early embryonic gene promoters [17]. UHRF1, which assists
DNMT1 in locating to hemimethylated sites [18], also targets
DNMT3A/3B for de novo methylation in ES cells [19]. However,
DNMT3L is expressed only during gametogenesis and embryonic
stages and not in somatic tissues [20,21]. Further, we and others
have recently shown that HP1 and UHRF1 are not required for
DNMT3A/3B’s association with nucleosomes [22] and G9a does
not affect maintenance of DNA methylation in somatic cells
[23,24]. Thus, other mechanisms must exist to ensure proper
localization of these enzymes to silent chromatin regions in
somatic cells [25], enabling faithful maintenance of methylated
states.
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DNMT3A/3B within a somatic cell are strongly anchored to
nucleosomes containing methylated DNA with little free
DNMT3A/3B proteins existing [22,26]. Here we show that the
presence of such methylated regions is essential for DNMT3A/
3B’s association with chromatin and quite unexpectedly, also for
maintaining the cellular levels of these enzymes. Reduction in
DNA methylation levels results in reduced DNMT3A/3B binding
to nucleosomes accompanied by selective degradation of the free
enzymes by the cellular machinery. Restoration of DNA
methylation increases DNMT3A/3B protein levels through their
stabilization on nucleosomes. Further, pre-existing methylation
stimulates propagation of DNA methylation in vivo by stably
anchoring DNMT3A/3B to nucleosomes. DNMT3A/3B work
synergistically to propagate methylation patterns with DNMT3B
stimulating DNMT3A activity by promoting its association with
nucleosomes, similar to DNMT3L. Taken together, these data
suggest an inheritance model where DNMT3A/3B remain
localized to silent methylated domains by binding to nucleosomes
containing methylated DNA, enabling faithful maintenance of
methylated states in cooperation with DNMT1; while non-
anchored DNMT3A/3B enzymes get selectively degraded pre-
venting spurious de novo methylation.
Results
DNMT3A protein level decreases on depletion of global
DNA methylation
In somatic cells, DNMT3A/3B remain bound to nucleosomes
containing methylated DNA [22]. To investigate the role of DNA
methylation in this binding, we used a series of HCT116 colon
cancer cells with homozygous deletions for DNMT1 (DNMT1
DE2-5;
1KO) [27,28], DNMT3B (DNMT3B




DKO) and consequently different levels of genomic DNA
methylation [7]. For the DKO cells, which still contain residual
DNMT1 activity [28], we used two clones for our analysis, DKO1
and DKO8, having lost ,95% and ,50% DNA methylation
respectively [7]. RT-PCR analysis of DNMT3A, DNMT3B and
DNMT1 transcript levels in the various HCT116 derivative cell
lines showed similar or higher levels of DNMT3A1 transcripts in
HCT116 knockout cell lines compared to WT HCT116; reduced
levels of DNMT1
DE2-5 hypomorph transcripts in 1KO and the two
DKO clones, with relatively higher expression in the DKO8 clone
and no detectable levels of DNMT3B transcripts in 3BKO and
both DKO cell lines, consistent with previous data [7,28]
(Figure 1A).
Next we examined DNMT protein levels in these cell lines
through immunoblotting of nuclear extracts. Similar to mRNA
analysis, DNMT3B and DNMT1 protein levels were severely
reduced in the respective knockout cell lines (Figure 1B).
Surprisingly, while DNMT3A mRNA levels were higher in both
DKO clones, we found dramatically reduced DNMT3A protein in
them compared to WT HCT116 cells. Similar reductions in
DNMT3A protein levels were observed in whole cell lysates of
both DKO cells, suggesting that the reduced nuclear levels are not
the result of protein mislocalization (Figure S1). These findings
were further confirmed by immunofluorescence analyses of
HCT116 and DKO cells which displayed similar reduction in
DNMT3A protein levels in DKO cells as observed in western blots
of their nuclear extracts. Moreover, the residual DNMT3A
protein displayed similar nuclear distribution in DKO cells as in
WT HCT116 cells, confirming that its reduced nuclear levels in
the DKO cells are not due to protein mislocalization (Figure S2).
G9a, another chromatin-modifying protein, did not display such
large changes in protein levels in HCT116 knockout cell lines
(Figure 1B).
Assessment of global DNA methylation levels using methyla-
tion-sensitive restriction enzymes revealed a direct correlation
between the amount of DNMT3A protein and level of
methylation retained in the knockout cells, suggesting a possible
role of DNA methylation in maintaining cellular DNMT3A levels
(Figure 1B, 1C). DKO8 cells, which had retained higher DNA
methylation levels, showed higher DNMT3A protein compared to
the minimal amount present in the severely hypomethylated
DKO1 cells. Since no such decrease in DNMT3A protein was
observed in the single DNMT1 and DNMT3B knockout cells (1KO
and 3BKO respectively), which retained substantial levels of DNA
methylation, maintenance of DNMT3A levels through possible
protein-protein interactions with DNMT1 and/or DNMT3B
seems unlikely.
Residual DNMT3A protein remains tightly bound to
chromatin in the DKO cells
We have previously shown that DNMT3A/3B strongly
associate with methylated chromatin regions [22]. To determine
whether the residual DNMT3A protein in hypomethylated DKO
cells retains similar affinity for chromatin as in WT HCT116 cells,
we performed a salt extraction experiment as described previously
[22]. Purified nuclei from HCT116 and DKO1 cells were
incubated in buffers with increasing concentrations (50 mM to
400 mM) of NaCl. Nuclear pellet and supernatant fractions were
independently analyzed through western blot analysis. As
expected, similar amounts of core histones remained inside the
extracted nuclei under all salt concentrations. In HCT116 cells,
the DNMT3A protein level remained almost constant within the
nuclei up to 400 mM NaCl indicating a strong binding affinity for
chromatin (Figure 2A), whereas other chromatin associated
proteins such as EZH2 and G9a showed relatively weaker binding
affinities with substantial amounts detected in the supernatant at
more than 200 mM NaCl concentrations. Interestingly, the
Author Summary
Proper inheritance of DNA methylation patterns is
essential for preserving cellular identity and preventing
malignant cellular transformation. In mammals, DNMT3A/
3B, the de novo methyltransferases, establish the DNA
methylation patterns during development and then
maintain them in co-operation with the maintenance
methyltransferase, DNMT1, through cell divisions. Howev-
er, the mechanisms by which DNMT3A/3B assist DNMT1 in
faithful inheritance of methylation patterns in somatic cells
while guarding against aberrant de novo DNA methylation
are still unclear. In this study, we present a novel principle
of enzyme regulation where the levels of the catalyzing
enzymes, DNMT3A/3B, are determined by the level of their
own enzymatic product, i.e. 5-methylcytosine itself.
Through biochemical analyses, we have shown that
binding of DNMT3A/3B to nucleosomes with methylated
DNA stabilizes these proteins, enabling faithful propaga-
tion of methylation patterns through cell divisions.
However, reduction in DNA methylation results in dimin-
ished nucleosome binding of DNMT3A/3B and subsequent
degradation of the free DNMT3A/3B proteins. This novel
self-regulatory inheritance mechanism not only ensures
faithful somatic propagation of methylated states but also
prevents aberrant de novo methylation by causing
degradation of free DNMT3A/3B enzymes.
DNMT3A/3B Stabilization on Methylated Nucleosomes
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greatly reduced in comparison to WT HCT116, also remained
tightly associated with the chromatin at all salt concentrations
(Figure 2A), possibly binding to the few methylated regions
remaining in the DKO1 cells. Minimal DNMT3A protein could
be detected in the supernatant fractions (50 to 300 mM NaCl) of
the DKO1 cells. These data suggest that binding to methylated
chromatin regions might be essential for maintaining the stability
of DNMT3A protein and that any free protein unable to bind to
chromatin in the absence of DNA methylation possibly gets
rapidly degraded by the cellular machinery. We did observe some
DNMT3A protein dissociating from the chromatin at 400 mM
NaCl in DKO1 cells but not in HCT116 cells suggesting a
reduction in chromatin binding affinity of DNMT3A in
hypomethylated DKO1 cells compared to heavily methylated
WT HCT116 cells (Figure 2A). Meanwhile, EZH2 and G9a
showed weaker binding to chromatin in DKO1 cells, similar to
that observed in WT HCT116. Taken together, these data suggest
that binding to methylated chromatin regions may be critical for
stabilization of DNMT3A protein.
Decreased protein stability of DNMT3A in
hypomethylated DKO cells
To assess whether the dramatic transcription-independent
decrease in steady-state levels of DNMT3A protein observed in
hypomethylated DKO cells was due to altered protein stability, we
treated WT HCT116 and DKO8 cells with the protein synthesis
inhibitor cycloheximide (CHX) [29] and measured the DNMT3A
protein remaining at different time points after treatment.
DNMT3A was stable in WT HCT116 cells with 93% still
remaining after 6 hrs of CHX treatment (Figure 2B). However, in
DKO8 cells, DNMT3A was very unstable with its level rapidly
decreasing to 49% 2 hrs after treatment. The half-life of DNMT3A
protein decreased dramatically from 16 hrs in WT HCT116 to
Figure 1. Transcription-independent decrease in DNMT3A protein level in hypomethylated DKO cells that contain severely
impaired DNMT1 activity. (A) DNMT3A, DNMT3B and DNMT1 mRNA levels in wild-type (WT) HCT116 and different knockout cell lines were
measured by RT-PCR. Primers used for RT-PCR were specific for DNMT3A1, DNMT3B1 and DNMT1 isoforms (refer to Table S1). Results are normalized
to GAPDH mRNA levels. Data represents mean and standard deviation of triplicate PCR reactions from a single experiment, representative of two
independent biological replicate experiments. (B) Western blot analysis of nuclear extracts from various HCT116 derivative cell lines using different
antibodies. In order to detect the truncated DNMT1
DE2-5 hypomorph expressed in 1KO and DKO cells, an antibody directed against the C-terminus of
DNMT1 was used. (C) DNA methylation analysis of WT HCT116 and knockout cell lines using methylation-sensitive restriction enzymes. Genomic DNA
isolated from the cells was digested with HpaII or MspI enzymes and the methylation level estimated as described in the Materials and Methods
section. Data is presented as percentage of methylation retained compared to WT HCT116 methylation levels. Data represents mean and SEM of
three independent replicate experiments.
doi:10.1371/journal.pgen.1001286.g001
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PLoS Genetics | www.plosgenetics.org 3 February 2011 | Volume 7 | Issue 2 | e1001286Figure 2. DNMT3A chromatin binding affinity and protein stability in WT HCT116 and DKO cells. (A) Nuclei purified from WT HCT116
and DKO1 cells were incubated in nondenaturing extraction buffers containing 50 to 400 mM NaCl for 5 min. Equivalent volumes of both
supernatant and pellet fractions were subjected to western blot analysis using specific antibodies. Ponceau S staining shows core histones transferred
onto the membrane from the SDS/PAGE gel. For detecting low levels of DNMT3A in DKO1 cells, blots for both the supernatant and pellet fractions
from DKO1 cells were overexposed for 5 fold more time duration compared to HCT116 cells, as indicated by *. (B) WT HCT116 and DKO8 cells were
treated with cycloheximide (CHX) and the levels of DNMT3A protein remaining at different time points after treatment were determined by western
blotting of nuclear extracts. p53 and actin were used as positive and loading controls, respectively. Data presented is from a single experiment,
representative of two independent biological replicate experiments.
doi:10.1371/journal.pgen.1001286.g002
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decrease in DNMT3A protein level in DKO8 cells within the first
2 hrs of CHX treatment, a fraction of DNMT3A protein remained
stable thereafter till the 8 hr time point (Figure 2B). This fraction
may possibly represent the stable DNMT3A protein bound to the
methylated chromatin regions in DKO8 cells, similar to that
observed in DKO1 cells (Figure 2A). Taken together, these data
indicate that a decrease in DNA methylation results in destabili-
zation of DNMT3A protein, possibly due to reduced chromatin
binding in the absence of methylated DNAregions, the main sites of
DNMT3A/3B binding [22].
Restoration of global DNA methylation rescues DNMT3A
protein level
To ascertain if depletion of DNA methylation is primarily
responsible for the decrease in DNMT3A protein, we sought to
restore DNA methylation in the DKO cells. We expressed Myc-
tagged DNMT3B1, DDNMT3B2 [30] or DNMT3L in DKO1 and
DKO8 cells using a lentiviral system and confirmed expression of
the relevant proteins by immunoblotting (Figure 3A). We did not
use DNMT1 for the restoration of DNA methylation in DKO cells
since expression of exogenous DNMT1 in DKOcells haspreviously
been shown to result only in partial increase in DNA methylation
[31]. More importantly, DNMT1 expression failed to restore
methylation in these cells at the repetitive elements, the key sites of
DNMT3A/3B binding [31]. Global DNA methylation levels in
infected DKO cells were measured 8 weeks post-infection using
methylation-sensitive restriction enzymes. Since DKO cells possess
very low levels of a hypomorph of DNMT1 [28], the primary
maintenance methyltransferase in the cell, very low levels of
DNMT3A protein and no DNMT3B protein, it required a long
time (,8 weeks) to achieve restoration of DNA methylation in these
cells. After 8 weeks of infection, we observed increased DNA
methylation in both DKOcell lines infected with DNMT constructs
compared to empty vector (E/V) controls (Figure 3B). Even though
there was equivalent mRNA expression of exogenous DNMT
enzymes in the two DKO clones (Figure S4), DKO8 cells, with
higher baseline methylation levels, showed a greater increase in
methylation compared to hypomethylated DKO1 cells for each
individual construct. Moreover, the increase in methylation in the
infected DKO cells was preferentially localized to loci having low-
levelsof pre-existingmethylationand minimal de novo methylationof
previously unmodified sites could be observed (De Carvalho D. and
Sharma S. et. al., unpublished observations), indicating that DKO
cells possess similar patterns of chromatin states as present in the
parental WT HCT116 cells, including histone modifications (such
as H3K4me3 and H2A.Z etc.) which are involved in guiding DNA
methylationtospecificgenomic loci[6].Theseresultsalsoindicate a
stimulatory effect of pre-existing methylation [32] on DNA
methylation by DNMTs in vivo, possibly through stabilization of de
novo DNMT3A/3B enzymes on methylated nucleosomes as
suggested by their higher protein levels in DKO8 cells (Figure 1B,
Figure 3A). This process may further be enhanced by the higher
levels of DNMT1 hypomorph present in DKO8 cells [33]
(Figure 1B). Within each DKO clone, exogenous DNMT3L
expressing cells showed the most robust increase in methylation
followed by DNMT3B1 and DDNMT3B2 expressing cells
respectively, re-emphasizing the strong stimulatory effect of
DNMT3L on DNMT3A/3B activity observed in ES cells [12].
These methylation data were further confirmed through Illumina
Infinium analysis [34] for each infected cell line (data not shown).
Interestingly, immunoblotting of nuclear extracts revealed a
substantialtranscription-independent increase inDNMT3Aprotein
level in all DNMT infected DKO cell lines (Figure 3C, Figure S5).
Moreover, the increase in DNMT3A correlated with the increase in
global DNA methylation levels (Figure 3C, 3B). Considering that
DNMT3A primarily associates with methylated chromatin regions
[22], these data suggest that presence of such methylated regions is
required for maintaining its protein level in somatic cells.
DNA methylation–induced DNMT3A increase is mediated
by strong anchoring to nucleosomes
To examine whether the increase in DNMT3A protein
observed upon restoration of DNA methylation is mediated by
binding to nucleosomes, we used sucrose density gradient analysis
which allows for the study of in vivo interactions between the
chromatin modification enzymes and their actual nucleosomal
substrates in the native state [22]. Mononucleosomal digests
prepared by extensive micrococcal nuclease (MNase) digestion of
nuclei from infected DKO8 cells, expressing either E/V, Myc-
tagged DNMT3B1, DDNMT3B2 or DNMT3L, were subjected to
fractionation on sucrose gradients containing 300 mM NaCl.
Western blot analysis showed similar nucleosomal profile in all
gradients with mononucleosomes forming a peak at fraction 6
(Figure 4). The DNMT fusion proteins displayed distinct
sedimentation profiles indicating different nucleosome binding
affinities. DNMT3B1 associated strongly with nucleosomes while
the truncated DDNMT3B2 variant showed weak association with
nucleosomes with a substantial amount of DDNMT3B2 sediment-
ing in nucleosome-free fractions indicating an essential role of the
N-terminal region in strong nucleosomal binding, consistent with
previous data [22]. However, analysis of various other truncated
DNMT3B1 proteins, which contained the N-terminal region but
lacked other protein regions (such as the catalytic, PHD and/or
PWWP domains), revealed weak nucleosome binding for all
truncated proteins (data not shown). These data suggest that
DNMT3B requires a full-length protein structure and synergistic
activity of its various domains for achieving strong nucleosome
binding. DNMT3L showed a bimodal distribution having both
nucleosome-free and nucleosome-bound protein (fractions 1–4
and 5–16 respectively). Strikingly, the increased DNMT3A protein
in all of the infected cell lines remained strongly associated with
nucleosomes similar to that in E/V control, independent of the
nucleosome binding affinities of the exogenous proteins, suggesting
a nucleosome anchorage dependent stabilization of the protein.
DNMT3A formed a peak at fraction 7 in DNMT3B1 and
DDNMT3B2 expressing cells. In DNMT3L expressing cells, the
peak was shifted to fraction 9, indicating the formation of heavier
DNMT3A-DNMT3L tetramer encasing the nucleosome [35]. It
might also be possible that DNMT3A-DNMT3L tetramer bound
nucleosomal regions may be more resistant to MNase digestion
and be responsible for this shift. We did not observe any
DNMT3A in the nucleosome-free fractions (1–4) co-sedimenting
with the unbound pool of DDNMT3B2 or DNMT3L fusion
proteins (Figure 4), suggesting that the increase in DNMT3A is not
due to stabilization through protein-protein interactions with the
exogenous proteins but is actually mediated by its binding to
nucleosomes upon increase in methylation. Taken together, these
data suggest that DNMT3A protein is stabilized by binding to
nucleosomes containing its own product (i.e. methylated DNA),
which is essential for maintaining its cellular levels.
Reduced nucleosome binding and degradation of
unbound DNMT3B upon depletion of DNA methylation
DNMT3B, like DNMT3A, also compartmentalizes to methyl-
ated regions in somatic cells via strong anchoring to nucleosomes
containing methylated DNA [22,26]. To examine whether
DNMT3A/3B Stabilization on Methylated Nucleosomes
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dependent manner, we expressed Myc-tagged DNMT3B1 in three
DNMT3B-knockout HCT116 cell lines, 3BKO, DKO8 and
DKO1, which possess 86%, 27% and 6% of total genomic DNA
methylation respectively (Figure 1C). We first tested mRNA and
protein expression of the exogenous DNMT3B1 in these cell lines.
Interestingly, while DNMT3B1 mRNA levels were similar in all
infected cell lines, we found dramatically reduced DNMT3B1
protein, similar to DNMT3A, in severely hypomethylated DKO1
cells in comparison to 3BKO and DKO8 cells (Figure 5A, 5B).
To assess whether the decrease in DNMT3B1 resulted from a
reduction in binding affinity for nucleosomes in hypomethylated
cells, we tested its distribution in mononucleosomal digests
fractionated on 300 mM NaCl containing sucrose gradients. In
3BKO and DKO8 cells, the exogeneous DNMT3B1 showed
strong association with nucleosomes similar to endogeneous
DNMT3A (Figure 5C, Figure 4). However, DNMT3B1 weakly
associated with nucleosomes in severely hypomethylated DKO1
cells with the bulk of the overexpressed protein sedimenting in
nucleosome-free fractions (2–4), suggesting a dramatic reduction in
nucleosome binding affinity upon depletion of DNA methylation.
Since the increase in methylation in the infected DKO cells was
preferentially localized to the same loci which were originally
methylated in the parental HCT116 cells, it suggests that DKO
cells possess similar patterns of histone modifications involved in
guiding DNA methylation as present in WT HCT116 cells (De
Carvalho D. and Sharma S. et. al., unpublished observations).
Therefore, taken together, these data strongly suggest that the
reduction in nucleosome binding affinity of DNMT3A/3B
observed in DKO cells results from depletion of DNA methylation
and is not due to clonal variation of global chromatin states.
To further confirm this phenomenon, we subjected Myc-tagged
DNMT3B1 expressing DKO1 cells to CHX treatment and
analyzed protein stability of the nucleosome-bound and -free
Figure 3. Increase in DNA methylation restores the DNMT3A protein level in DKO cells. (A) Expression of Myc-tagged DNMT3B1,
DDNMT3B2 and DNMT3L proteins, infected using a lentiviral system, in DKO cells was confirmed by immunoblotting of nuclear extracts using a Myc
antibody. (B) DNA methylation analysis of infected DKO cells using methylation-sensitive restriction enzymes. Genomic DNA was isolated from
infected cells eight weeks after infection and methylation level was estimated as described in Figure 1. Data is presented as the percentage of
methylation retained compared to WT HCT116 methylation levels. Data represents mean and SEM of three independent replicate experiments. (C)
Western blot analysis of nuclear extracts, prepared from infected DKO cells and different HCT116 derivative cell lines, using a DNMT3A antibody.
Histone H3 was used as the loading control. Data presented in this figure is representative of two biological replicate experiments. E/V: Empty Vector.
doi:10.1371/journal.pgen.1001286.g003
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on endogenous DNMT3A enzyme, the overexpressed free
DNMT3B1 protein underwent rapid degradation compared to
the stable nucleosome-bound DNMT3B1 protein, clearly display-
ing the instability of the unbound protein (Figure 5D). Such
degradation was inhibited by treatment with the proteosome
inhibitor MG132, indicating the role of proteosomal pathway in
this process. However, we could not rescue degradation of
DNMT3A protein in DKO cells using MG132 treatment
suggesting possible involvement of other mechanisms in its
degradation (data not shown). The phenomenon of destabilization
and selective degradation of unbound DNMT3A/3B proteins
could also be observed in the case of Myc-DDNMT3B2 which
showed substantially lower protein levels compared to Myc-
DNMT3B1 in DKO8 cells even when both genes were expressed
at similar mRNA levels (Figure 3A, Figure S4). Since Myc-
DDNMT3B2 associated weakly with nucleosomes while Myc-
DNMT3B1 bound strongly to nucleosomes in DKO8 cells
(Figure 4), the reduction in Myc-DDNMT3B2 levels possibly
results from a decrease in protein stability of the unbound Myc-
DDNMT3B2 protein, similar to that previously observed for
DNMT3A and 3B in DKO1 cells. Taken together, these data
show that both DNMT3A/3B require the presence of DNA
methylation for tight binding to nucleosomes and subsequent
protein stabilization. Such a mechanism would enable faithful
inheritance of methylated states through proper compartmental-
ization of DNMT3A/3B while preventing spurious de novo
methylation through selective degradation of the free enzymes.
Synergistic activity of DNMT3A/3B is mediated by their
anchoring to nucleosomes
In ES cells, DNMT3A/3B strongly interact and mutually
stimulate each other’s activity, thus working synergistically to
establish genomic DNA methylation patterns during development
[36]. To ascertain whether a similar mechanism is involved in
propagation of DNA methylation in somatic cells, we expressed a
Myc-tagged catalytically-inactive DNMT3B1 mutant, having a
cysteine to serine alteration (position 657) which destroys catalytic
activity without compromising other functions [37], in DKO8 cells
and confirmed its protein expression by immunoblotting
(Figure 6A). To determine whether the DNMT3B1 mutant could
stimulate DNMT3A activity, we measured the global DNA
methylation level in the mutant expressing cells 8 weeks post-
infection. We observed a substantial increase in methylation,
demonstrating a stimulatory effect of DNMT3B on DNMT3A
activity, independent of catalytic activity (Figure 6B). Immuno-
Figure 4. The increased level of DNMT3A protein in infected DKO cells, which have increased levels of DNA methylation, remains
tightly bound to nucleosomes. Mononucleosomal digests prepared by extensive MNase digestion of infected DKO8 nuclei, were resolved by
ultracentrifugation on a sucrose density gradient (5% to 25%) containing 300 mM NaCl. Gradients were fractioned into 16 aliquots numbered 1–16
starting from the top of the centrifuge tube. To probe the distribution of proteins in each fraction, western blotting was performed with various
antibodies after TCA precipitation of proteins from each fraction. Ponceau S staining shows core histones transferred onto the membrane from the
SDS/PAGE gel. Mononucleosomes peaked in fraction 6 and the small proportion of higher order oligonucleosomes remaining in the digests
sedimented in later fractions. The control lanes on the gels were loaded with unfractionated nuclear extract to monitor the quality of the
immunostaining of the membranes. The upper band in the DNMT3A blot for Myc-DNMT3B1 expressing DKO8 cells denotes endogenous DNMT3A.
The lower band represents the residual signal of the exogenous Myc-DNMT3B1, which was probed earlier on the same membrane.
doi:10.1371/journal.pgen.1001286.g004
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levels. (A) RT-PCR analysis was performed using primers for Myc-DNMT3B1 to assess its mRNA levels in infected 3BKO, DKO8 and DKO1 cells. The
results are normalized to GAPDH mRNA levels. Data represents mean and standard deviation of triplicate PCR reactions from a single experiment,
representative of two biological replicate experiments. (B) Western blot analysis of nuclear extracts from infected 3BKO, DKO8 and DKO1 cells.
Exogenous DNMT3B1 was detected with Myc antibody. (C) Nuclei extracted from infected cells were extensively digested with MNase and
mononucleosomes released from them were resolved by ultracentrifugation on a sucrose density gradient (5% to 25%) containing 300 mM NaCl. The
gradients were fractionated and analyzed as described previously. (D) DKO1 cells expressing Myc-DNMT3B1 were treated with cycloheximide (CHX)
for different time points. The proteosome inhibitor, MG132 was added 2 hr prior to CHX treatment. Nuclei extracted from each sample were then
incubated in 500 ml of ice-cold RSB containing 300 mM NaCl, 0.25 M sucrose and protease inhibitors at 4uC for 5 min. Supernatant and nuclear
fractions were separated by centrifugation at low speed and equivalent protein amounts from each were subjected to western blot analysis. Data is
representative of two biological replicate experiments.
doi:10.1371/journal.pgen.1001286.g005
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strongly interacted with DNMT3A, similar to WT DNMT3B1,
suggesting a DNMT3L-like stimulation mechanism which occurs
through physical interaction of the two proteins [12] (Figure S6).
Along with an increase in DNA methylation, we observed a
substantial increase in endogenous DNMT3A protein levels in
mutant DNMT3B1 expressing cells (Figure 6A), similar to WT
DNMT3B1 expressing cells, suggesting DNA methylation induced
stabilization of DNMT3A protein. Similar results were obtained
upon expression of a catalytically-inactive DDNMT3B2 mutant in
DKO8 cells indicating a stimulatory effect of DDNMT3B2 on
DNMT3A activity, occurring through its physical interaction with
the DNMT3A protein as shown by immunoprecipitation exper-
iments (Figures S7, S6).
In ES cells, stimulation of DNMT3A/3B activity by DNMT3L
partially occurs through increased association of the enzymes with
the substrate DNA, allowing these slow acting enzymes to efficiently
methylate the substrate [38]. To examine whether stimulation of
DNMT3A by DNMT3B in somatic cells occurs through a similar
mechanism in a nucleosomal context, we analyzed mononucleoso-
mal digests from DNMT3B1 mutant expressing cells on 300 mM
sucrose density gradients. All cellular DNMT3A in infected 3BKO
and DKO8 cell lines was found tightly anchored to nucleosomes
suggesting that its stimulation by DNMT3B1 occurs through an
increased binding to nucleosomes (Figure 6C). We could not detect
DNMT3A in DKO1 cells in this assay due to its extremely low
levels. In DKO8 cells expressing the mutant DDNMT3B2, all
cellular DNMT3A protein was found strongly anchored to
Figure 6. DNMT3B catalytically-inactive mutant stimulates DNA methylation by increasing DNMT3A binding to nucleosomes. (A)
Western blot analysis of nuclear extracts from DKO8 cells expressing wild-type and catalytically-inactive Myc-tagged DNMT3B1 mutant (mut) using
specific antibodies. (B) DNA methylation analysis of infected DKO8 cells using methylation-sensitive restriction enzymes. Genomic DNA was isolated
from infected cells eight weeks after infection and methylation level was estimated as described in Figure 1. Data is presented as percentage of total
genomic methylation present compared to WT HCT116 methylation levels. Data represents mean and SEM of three independent replicate
experiments. (C) Mononucleosomes released from nuclei, extensively digested with MNase, were resolved by ultracentrifugation on a sucrose density
gradient (5% to 25%) containing 300 mM NaCl. The gradients were fractionated and analyzed as described previously. The low levels of Myc-
mutDNMT3B1 and DNMT3A observed in DKO8 gradient fractions compared to control lanes is due to the poor yield obtained in TCA precipitation of
these gradient fractions. E/V: Empty Vector; mut: mutant.
doi:10.1371/journal.pgen.1001286.g006
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DNMT3A by DDNMT3B2 is mediated by their binding to
nucleosomes (Figure S7). The DNMT3B1 and DDNMT3B2
mutants displayed similar binding affinity for nucleosomes as their
WT counterpartssuggesting that theircatalyticactivityhaslittlerole
in nucleosome binding. Taken together, these data show that in vivo
stimulation of DNMT3A by DNMT3B occurs through an
increased binding to nucleosomes, similar to that observed with
DNMT3L, enabling efficient methylation from these slow acting de
novo enzymes and their consequent stabilization through continued
association with such methylated regions.
Discussion
Proper maintenance of epigenetic modifications within specific
chromatin domains is critical for preserving cellular identity.
Recently, a common theme for inheritance of histone marks has
emerged where the mark recruits and retains its own modifying
enzyme and triggers renewal by stimulating that enzyme through
possible allosteric activation mechanisms [39,40,41]. Our work
suggests involvement of a similar mechanism in maintenance of
DNA methylation patterns through DNMT3A/3B in somatic cells.
We and others have previously shown that DNMT3A/3B, but
not DNMT1, are strongly anchored to nucleosomes containing
methylated DNA in somatic cells [22,26]. Our current data shows
that the presence of DNA methylation is essential for association of
DNMT3A/3B with chromatin and also for maintaining the
cellular levels of the DNMT3A/3B enzymes, thereby creating a
homeostatic inheritance system. Such methylation directed
binding stimulates DNA methylation at target loci in vivo ensuring
faithful maintenance of methylation patterns, a phenomenon
previously observed in inheritance of the polycomb mark [42].
Since DNMT3A/3B are slow acting enzymes compared to
DNMT1 [38], stable association with their target methylated
regions would be key for their ability to properly maintain
methylated states. We further show that DNMT3A/3B work
synergistically in this maintenance process and DNMT3B
stimulates DNMT3A activity through increased association with
nucleosomes, similar to DNMT3L. Thus, promotion of DNA
methylation by selective binding of DNMT3A/3B to nucleosomes
containing pre-existing methylation may serve as a critical positive
feed-back loop mechanism essential for faithful propagation of
epigenetic states through somatic cell divisions [25,43,44].
Another key finding of our work is the selective degradation of
free DNMT3A/3B proteins which could not bind to chromatin in
the absence of pre-existing DNA methylation in somatic cells. In
ES cells and PGCs (primordial germ cells), DNMT3A/3B are
required for establishment of global DNA methylation patterns.
Therefore, in these cells, DNMT3A/3B are highly expressed at
the transcriptional level and their methylation activity is strongly
stimulated by DNMT3L [12,45]. However, in somatic cells, the
main role of the de novo DNMT3A/3B enzymes is to assist
DNMT1 in proper maintenance of pre-established DNA methyl-
ation patterns and prevention of de novo methylation of previously
unmethylated regions is required [11,45]. Therefore, DNMT3A/
3B mRNA expression is substantially downregulated and
DNMT3L is not expressed in differentiated somatic tissues in
order to prevent any aberrant de novo methylation [20,45]. Our
data suggest that to further regulate this maintenance process,
DNMT3A/3B protein levels are post-translationally regulated by
the levels of pre-existing DNA methylation in somatic cells.
Selective degradation of free DNMT3A/3B enzymes may help
explain how somatic cells, which still express low levels of de novo
DNMT3A/3B enzymes, prevent aberrant de novo methylation of
CpG islands. Our data suggests that once DNMT3A/3B are
recruited to methylated chromatin domains, pre-existing methyl-
ation stabilizes their binding to such regions and enables faithful
propagation of methylated states. However, in absence of DNA
methylation, as would be the case with unmethylated CpG islands,
these slow acting enzymes are unable to stably bind to the
chromatin. The resulting free de novo enzymes, which could
potentially cause spurious methylation, are then selectively
degraded by the cellular machinery possibly through recognition
of an altered conformation in the unbound state (Figure 7). As
shown in the model, in hypomethylated DKO (DNMT1
DE2-5/
DNMT3B
2/2) cells, DNMT3A loses its ability to bind to
nucleosomes resulting in destabilization and selective degradation
of free DNMT3A protein while the residual DNMT3A remains
bound to the remaining few methylated chromatin regions
(Figure 7). Since exogenous Myc-DNMT3B1 also displayed a
similar DNA methylation-dependent stabilization upon nucleo-
somes, it suggests that a similar model might apply to the
regulation of DNMT3B enzyme in somatic cells. Our data
indicates that unbound DNMT3B1 is degraded through the
proteosomal pathway but how DNMT3A is selectively targeted for
degradation in somatic cells is still unclear. Future studies are
required to further understand the exact mechanisms involved in
the selective degradation of unbound DNMT3A/3B enzymes.
Histone methyltransferases, however, are not regulated in such a
manner and have been found to exist in both free and chromatin-
bound forms within nuclei. This difference can be partially
explained by the fact that histone marks are far more dynamic in
nature, actively regulated by the combined action of histone
methyltransferases and demethylases [46], compared to DNA
methylation which is still believed to be a relatively stable mark in
differentiated tissues [6].
While initial recruitment of DNMT3A/3B to methylated regions
may involve other proteins, our data strongly suggests that their
anchoring to chromatin primarily depends upon pre-existing DNA
methylation. However, in addition to DNA methylation, certain
histone modifications and accessory proteins may also help in
selective compartmentalization of these enzymes. For instance,
unmethylated H3K4, recently shown to bind DNMT3A [47], may
assist in stable binding to silent domains. Recruitment of
DNMT3A/3B to such domains may involve UHRF1 [19]. On
the other hand, proteins like H2A.Z, CTCF and H3K4me3 etc.
which are antagonistic to DNA methylation [14,48,49], may
occlude binding of DNMT3A/3B to active/poised regions, thus
constraining their activities to silent methylated domains only.
Recently, Witcher and Emerson [50] have shown that loss of such
boundary elements indeed results in aberrant spreading of DNA
methylation beyond methylated domains. Our data suggests that
these aberrations may involve DNMT3A/3B enzymes which
remain bound to methylated regions [22]. During tumorigenesis,
these de novo enzymes may progressively override the chromatin
boundaries, gradually spreading methylation beyond their specific
domains to the entire region [51] resulting in aberrant methylation
of genes in clusters – a common feature of cancer-specific
hypermethylation [52,53]. Such a mechanism may also help
explain why CpG island loci having pre-existing methylation in a
normal tissue are more susceptible to undergo de novo methylation in
cancer [54]. Moreover, ectopic de novo methylation, correlated with
overexpression of DNMT3A/3B in several types of cancer [3], may
also be maintained and propagated through continued association
of DNMT3A/3B with such regions. DNA methylation inhibitors
like 5-aza-CdR, widely used to inhibit aberrant methylation in
cancer, target DNMTs by trapping them on DNA [55]. Since these
hypomethylating drugs trap DNMTs onto the DNA, it is not
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from nucleosomes and destabilization upon loss in DNA methyl-
ation observed in our experiments. Nevertheless, our data suggests
that destabilization of DNMT3A/3B upon removal of DNA
methylation may provide another mechanism for depletion of these
enzymes upon treatment with such hypomethylating drugs.
However, future studies are required to further understand these
mechanisms, focusing on factors determining proper compartmen-
talization of DNMT3A/3B to methylated regions and mechanisms
responsible for selective degradation of the unbound protein.
In conclusion, our data suggests a model for epigenetic
inheritance of DNA methylation in somatic tissues where pre-
existing methylation triggers its renewal by recruiting and
stabilizing DNMT3A/3B on methylated chromatin domains,
which then work synergistically to propagate DNA methylation
in co-operation with DNMT1. Such a mechanism not only
ensures faithful maintenance of methylated states but also guards
against aberrant methylation from the de novo DNMT3A/3B
enzymes.
Materials and Methods
Cell culture and drug treatment
HCT116 derivative cell lines were maintained in McCoy’s 5A
medium containing 10% inactivated fetal bovine serum, 100
units/ml penicillin and 100 mg/ml streptomycin. Puromycin was
included in the culture medium at 3 mg/ml to maintain infected
HCT116 derivative cell lines. When indicated, cycloheximide
(Sigma) was added to a final concentration of 50 mg/ml. The
proteosome inhibitor MG132 (Calbiochem) was used at 10 mM for
2 h prior to CHX treatment.
RNA isolation and RT-PCR
Detailed methods are described in Text S1.
Expression vector construction
Human 3B1, DDNMT3B2 and DNMT3L cDNA sequences
having the Myc tag DNA sequence ligated to their 59 ends were
amplified from the pIRESpuro/Myc constructs [22] (a modified
version of the pIRESpuro3 vector, Clontech), a generous gift from
Allen Yang (USC), using polymerase chain reaction (PCR). Myc-
tagged catalytically-inactive mutants of DNMT3B1 and
DDNMT3B2, having a cysteine to serine alteration in the catalytic
domain corresponding to position 657 of DNMT3B1 protein,
were prepared using a site-directed mutagenesis kit (Stratagene).
The mutation was confirmed by sequencing both strands of the
constructs. For preparation of the constructs, the lentivirus vector
pLJM1 was linearized using AgeI and EcoRI restriction enzymes
and the Myc tagged DNMT cDNAs were cloned in it using In-
Figure 7. Model for selective stabilization of DNMT3A/3B through anchoring to nucleosomes containing methylated DNA. (A) In
somatic cells, DNMT3A/3B remain bound to nucleosomes containing methylated DNA, enabling proper maintenance of methylated states in co-
operation with DNMT1, the maintenance enzyme, which copies the methylation pattern during replication by associating with the proliferating cell
nuclear antigen (PCNA). (B) When DNA methylation is lowered by genetic disruption of DNMT1 and DNMT3B in DKO cells, DNMT3A loses its ability to
bind to nucleosomes which results in destabilization and subsequent degradation of the protein. (C) Restoration of DNA methylation in such
hypomethylated cells, through expression of exogenous DNMT3B (WT or mut) or DNMT3L, increases DNMT3A protein levels by enabling it to bind to
nucleosomes again which results in stabilization of DNMT3A protein. Exogenous DNMT3B (WT or mut) also binds strongly to nucleosomes in the
presence of DNA methylation and synergistically increases methylation along with DNMT3A while the excess free DNMT3B protein, which could not
anchor to the nucleosomes, gets degraded by the proteosomal machinery. mut: mutant.
doi:10.1371/journal.pgen.1001286.g007
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turer’s protocol. For lentivirus production, the vesicular stomatitis
virus envelope protein G expression construct pMD.G1, the
packaging vector pCMV DR8.91 and the transfer vector pLJM1
were used as described previously [56]. Infected HCT116
derivative cells, stably expressing various DNMTs, were selected
in the presence of 3 mg/ml puromycin for three weeks.
Nuclear and whole-cell lysates preparation
Detailed methods are described in Text S1.
Salt extraction of nuclei
Nuclei from 5610
6 cells were incubated in 500 ml of ice-cold
RSB containing 0.25 M sucrose, protease inhibitors and various
concentrations of NaCl for 5 min at 4uC. Nuclei were then
harvested by microcentrifugation, separating the supernatant and
the pellet fractions. Nuclear pellets were resuspended in RIPA
buffer and subjected to sonication. Proteins in the supernatant
were concentrated using TCA precipitation and later resuspended
in RIPA buffer. Equivalent volumes of supernatant and pellet
fractions were added to SDS loading buffer and subjected to
Western blotting.
MNase digestion and sucrose density gradient
centrifugation
MNase digestion and sucrose gradients experiments were
performed as described previously [22]. For details, see Text S1.
DNA methylation analysis
Genomic DNA (10 mg) isolated from various HCT116 deriv-
ative cell lines was digested with methylation-sensitive restriction
enzymes, HpaII or MspI (New England Biolabs), at 37uC over
night. The digested DNA was run on an agarose gel at low voltage
for 8 hrs in order to achieve good separation. The undigested
DNA band in each lane was then quantified using the
ImageQuant software. Percentage of genomic methylation present
was calculated using the formula:
% methylation ~ H{M ðÞ X 100 ðÞ = G,
where H= undigested with HpaII; M= undigested with MspI and
G= genomic DNA.
Supporting Information
Figure S1 Decrease in DNMT3A level in DKO cells is not due
to protein mislocalization. Western blot analysis of whole cell
extracts from various HCT116 derivative cell lines using
DNMT3A antibody. Actin was used as the loading control.
Found at: doi:10.1371/journal.pgen.1001286.s001 (0.80 MB TIF)
Figure S2 Residual DNMT3A protein remains localized within
nuclei in DKO cells. Co-cultured HCT116, DKO8 and DKO1
cells were immunostained for DNMT3A (green) using a rabbit
polyclonal DNMT3A antibody and their nuclei (blue) were stained
with 4,6-diamidino-2- phenylindole. Scale bar, 20 mm.
Found at: doi:10.1371/journal.pgen.1001286.s002 (3.53 MB TIF)
Figure S3 Decreased stability of DNMT3A protein in DKO8
cells compared to WT HCT116 cells. Quantitation of protein
bands shown in Figure 2B was done using Quantity One software
(Bio-Rad). The data points represent DNMT3A levels, normalized
to actin, at different time points presented as the fraction of protein
remaining compared to levels present before CHX treatment.
Straight lines represent linear regression adjustment of the
individual time points. The half-life of the DNMT3A protein
decreased from 16 hr in WT HCT116 to 7 hr in DKO8 cells. The
data presented is from a single experiment, which is representative
of two independent biological replicate experiments.
Found at: doi:10.1371/journal.pgen.1001286.s003 (0.29 MB TIF)
Figure S4 Similar levels of mRNA expression of exogenous
DNMTs in DKO8 and DKO1 cells. RT-PCR analysis was
performed using primers for DNMT3B to check Myc-DNMT3B1 &
Myc-DDNMT3B2 expression in DKO cells (see Table S1). The
results are normalized to GAPDH mRNA levels. Data represents
mean and standard deviation of triplicate PCR reactions from a
single experiment, which is representative of two independent
biological replicate experiments.
Found at: doi:10.1371/journal.pgen.1001286.s004 (0.33 MB TIF)
Figure S5 Increase in DNMT3A protein level in DKO cells,
upon expression of different Myc-DNMTs, is independent of
transcription. RT-PCR analysis was performed for analyzing
endogenous DNMT3A mRNA levels in the (A) DKO8 and (B)
DKO1 cells, 8 weeks after infection with different DNMTs. WT
HCT116, 1KO and 3BKO cell lines were also included in the
analysis. Results are normalized to PCNA mRNA levels. Data
represents mean and standard deviation of triplicate PCR re-
actions from a single experiment, which is representative of two
independent biological replicate experiments. E/V: Empty Vector.
Found at: doi:10.1371/journal.pgen.1001286.s005 (0.57 MB TIF)
Figure S6 DNMT3B1 and DDNMT3B2 catalytically-inactive
mutants interact with DNMT3A similar to wild-type DNMT3B1,
DDNMT3B2, and DNMT3L. Western blot analysis was used to
analyze proteins immunoprecipitated using Myc and DNMT3A
antibodies in DKO8 cells expressing (A) Myc-DNMT3B1 or Myc-
mut (mutant) DNMT3B1, (B) Myc-DDNMT3B2 or Myc- mut
(mutant) DDNMT3B2 and (C) Myc- DNMT3L. IgG and CD-8
antibodies were used as a negative control. Antibodies used for
immunoprecipitation (IP) are mentioned at the top and for
immunoblotting on the left. Very faint bands of co-immunoprecip-
itated DNMT3A were visible in IPs with Myc antibody in (A) and (B),
possibly due to very low levels of DNMT3A present in those cell lines.
In (C), the upper strong band in the Myc and CD-8 IP lanes
corresponds to the mouse IgG of the IP antibody while the lower
band is for Myc-DNMT3L. Input denotes mononucleosomaldigestes
prepared for immunoprecipitation experiments. mut: mutant
Found at: doi:10.1371/journal.pgen.1001286.s006 (0.84 MB TIF)
Figure S7 DDNMT3B2 catalytically-inactive mutant stimulates
DNMT3A activity through their interaction upon nucleosomes.
(A) Western blot analysis of nuclear extracts from DKO8 cells
expressing wild-type and catalytically-inactive Myc-tagged
DDNMT3B2 mutant (mut) using specific antibodies. (B) DNA
methylation analysis of infected DKO8 cells using methylation-
sensitive restriction enzymes. Genomic DNA was isolated from
infected cells eight weeks after infection and methylation level
was estimated as described in Figure 1. Data is presented as
percentage of total genomic methylation present compared to WT
HCT116 methylation levels. Data represents mean and SEM of
three independent replicate experiments. (C) Mononucleosomes
released from nuclei, extensively digested with MNase, were
resolved by ultracentrifugation on a sucrose density gradient
(5% to 25%) containing 300 mM NaCl. The gradients were
fractionated and analyzed as described previously. E/V: Empty
Vector; mut: mutant.
Found at: doi:10.1371/journal.pgen.1001286.s007 (0.63 MB TIF)
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Found at: doi:10.1371/journal.pgen.1001286.s008 (0.03 MB
DOC)
Text S1 Supplemental Materials and Methods.
Found at: doi:10.1371/journal.pgen.1001286.s009 (0.03 MB
DOC)
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